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Miscarriage is a condition that affects 10%–15% of all clinically recognized pregnancies, most of which occur in
the ﬁrst trimester. Approximately 50% of ﬁrst-trimester miscarriages result from fetal chromosome abnormalities.
Currently, G-banded chromosome analysis is used to determine if large-scale genetic imbalances are the cause of
these pregnancy losses. This technique relies on the culture of cells derived from the fetus, a technique that has
many limitations, including a high rate of culture failure, maternal overgrowth of fetal cells, and poor chromosome
morphology. Comparative genomic hybridization (CGH)–array analysis is a powerful new molecular cytogenetic
technique that allows genomewide analysis of DNA copy number. By hybridizing patient DNA and normal reference
DNA to arrays of genomic clones, unbalanced gains or losses of genetic material across the genome can be detected.
In this study, 41 product-of-conception (POC) samples, which were previously analyzed by G-banding, were tested
using CGH arrays to determine not only if the array could identify all reported abnormalities, but also whether
any previously undetected genomic imbalances would be discovered. The array methodology detected all abnor-
malities as reported by G-banding analysis and revealed new abnormalities in 4/41 (9.8%) cases. Of those, one
trisomy 21 POC was also mosaic for trisomy 20, one had a duplication of the 10q telomere region, one had an
interstitial deletion of chromosome 9p, and the fourth had an interstitial duplication of the Prader-Willi/Angelman
syndrome region on chromosome 15q, which, if maternally inherited, has been implicated in autism. This retro-
spective study demonstrates that the DNA-based CGH-array technology overcomes many of the limitations of
routine cytogenetic analysis of POC samples while enhancing the detection of fetal chromosome aberrations.
Introduction
Approximately 10%–15% of all clinically recognized
pregnancies end in miscarriage, most of which occur in
the ﬁrst trimester. Of these ﬁrst-trimester miscarriages,
∼50% are due to fetal chromosome abnormalities (Has-
sold et al. 1980), the majority of which (86%) arise from
numerical abnormalities, including trisomies,monosom-
ies, and polyploidies (triploidy or tetraploidy). Structural
abnormalities account for 6% of such losses, and other
abnormalities, such as single-gene mutations and mo-
saicism, account for 8% (Goddijn and Leschot 2000).
Cytogenetic analysis of tissue from spontaneous abor-
tions provides valuable insights into the cause of mis-
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carriage, which can eliminate further costly testing. In
addition, recurrence-risk estimates for subsequent preg-
nancies can also be determined. Routine cytogenetic an-
alysis relies on the successful culture of fetal tissue and
preparation of metaphase cells, a well-establishedmeth-
odology in clinical cytogenetics laboratories. However,
diagnosis in product of conception (POC) samples is
often hindered by a relatively high (10%–40%) rate of
tissue-culture failure (Lomax et al. 2000) and the sub-
optimal quality of chromosome preparations. In addi-
tion, selective overgrowth of maternally derived cells
can occur, thereby erroneously yielding a normal karyo-
type despite possible underlying fetal chromosomal ab-
normalities (Bell et al. 1999).
Comparative genomic hybridization (CGH) is a mo-
lecular cytogenetic technique in which ﬂuorescently la-
beled patient and control whole-genomic DNA is hy-
bridized to normal metaphase slides. Differential hy-
bridization signals allow the detection of unbalanced
gains and losses of chromosomal material across the
whole genome at a resolution of∼3–10Mb (Kallioniemi
et al. 1992; Kirchhoff et al. 2001). Recent studies have
shown that CGH analysis of DNA extracted from un-
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cultured or parafﬁn-embedded fetal tissue provides an
effective alternative for the detection of fetal chromo-
some anomalies (Daniely et al. 1998; Bell et al. 2001;
Fritz et al. 2001; Tabet et al. 2001). Many of the lim-
itations of routine G-banding analysis, including cell-
culture failure and poor chromosome morphology, are
circumvented by the use of genomic DNA. However,
this technique is limited by the inability to identify bal-
anced translocations, triploidies, and tetraploidies.
Since triploidies and tetraploidies are common ﬁndings
in POC samples, one group overcame this limitation by
subsequently using ﬂow cytometry on samples forwhich
CGH analysis yielded a normal result (Lomax et al.
2000).
A new molecular cytogenetic technique, CGH-array
analysis, has recently been developed. Although based
on the same principle as conventional CGH, array CGH
differs in that genomic clones from selected regions of
the genome replace the normal “control”metaphase cells
as the target DNA (Pinkel et al. 1998; Snijders et al.
2001). Since genomic clones are used as the target DNA,
the resolution of the technique is theoretically increased
to the size of an individual clone, depending on its size
and spacing. Therefore, rearrangements and deletions—
that are not visible by either routine G-banding analysis
or conventional CGH methods—can be detected.
CGH arrays have been successfully utilized to identify
ampliﬁcations and deletions in multiple cancer types
(Hodgson et al. 2001; Cai et al. 2002; Paris et al. 2003;
Schwaenen et al. 2003), and their use in studying con-
stitutional rearrangements is increasing (Veltman et al.
2002; Gunn et al. 2003; Ki et al. 2003; reviewed by
Albertson and Pinkel [2003] and Vissers et al. [2003]).
In this study, DNA arrays containing genomic clones for
every telomere, as well as clones for all of the microde-
letion syndromes and additional selected loci spanning
the genome, have been used to analyze 41 previously
karyotyped POC samples. The ability of array CGH to
not only verify all abnormalities found by G-banding
analysis but also to identify additional submicroscopic
rearrangements was retrospectively assessed to validate
the utility of array CGH in analyzing POC samples in
the clinical cytogenetics setting.
Material and Methods
Sample Collection, DNA Isolation, and Cytogenetic
Analysis
Fetal tissue samples were obtained from females who
experienced spontaneous pregnancy losses (20 wk), fol-
lowing approved institutional review board protocols.
After removal of the pregnancy tissue from the uterus,
the tissues were examined grossly, and a small portion
of chorionic villi was placed in a sterile container with
AmnioMAX media (GIBCO Invitrogen).
Chorionic villi were separated frommaternal deciduae
by use of a dissecting microscope, were dissociated using
trypsin and collagenase, and were initiated in culturewith
AmnioMAXmedia. Cells were established in culture and
grown on coverslips, as well as in T25 ﬂasks. The cul-
tures on coverslips were harvested for routineG-banding
analysis following standard protocols. For each sample,
20 metaphase cells were counted, and 5 were fully an-
alyzed. For DNA extraction, cells from two T25 ﬂasks
at 80% conﬂuency were trypsinized and washed in PBS.
DNA was isolated from these cells by use of the Pure-
Gene DNA isolation kit (Gentra Systems). Results from
G-banding analysis were blinded to the experimenters
before array analysis was initiated.
DNA Labeling, Array Hybridization, and Analysis
Test (POC) DNA was quantitated using a ﬂuorometer
and 100 ng each of test, and normal reference DNA
(from an individual of the opposite sex of the fetal sam-
ple) was labeled with Cyanine 3- and Cyanine 5-dCTP
ﬂuorescent nucleotides (Perkin-Elmer), respectively, by
use of the Microarray Random Priming Kit (Vysis/Ab-
bott). In brief, DNA was denatured at 100C for 10 min
and was cooled to 4C before the addition of Klenow
fragments and nucleotide mix. After incubation at 37C
for 2 h, the samples were digested using a 1:20 DNAse
dilution for 60 min at 15C. Unincorporated nucleotides
were then removed using Sephadex G-200 spin columns
(Amersham-Biosciences). Probes were precipitated with
3 M sodium acetate and 100% ethanol and were re-
suspended in 10 mM Tris, pH 8.0.
Test and reference DNA was prepared for hybridiza-
tion, according to manufacturer recommendations, with
the GenoSensor Array 300 Kit (Vysis/Abbott). Equal ali-
quots of labeled test and reference DNA were combined
in a tube with hybridization buffer, were denatured at
80C for 10 min, and were incubated for 1 h at 37C
to allow for blocking of repetitive sequences. The so-
lutions were then hybridized at 37C for 72 h with a
GenoSensor Array 300. This array contains 287 genomic
clones, including those for each human telomere, as well
as all of the known microdeletion syndromes and ad-
ditional selected loci representing each chromosome arm
(see ﬁg. A1 [online only]).
After hybridization, the arrays were washed in 50%
formamide/2# SSC at 40C and 1# SSC at 25C, and
coverslips were mounted to the array with 4′,6-diami-
dino-2-phenylindole (DAPI). Finally, the arrays were im-
aged and data analyzed using the GenoSensor Reader and
its accompanying software (Vysis/Abbott) (see table A
[online only], a tab-delimited ASCII ﬁle that can be im-
ported into a spreadsheet, for raw array data).
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Targets with mean test-over-reference (T/R) ratios !0.8
were considered suggestive of losses, whereas those with
ratios 11.2 were considered suggestive of gains. If ques-
tionable results were found on one array, the assay was
repeated on a second array to conﬁrm the results as a
true gain or loss or to exclude such results as false posi-
tives. The data from one clone from the telomeric region
of 4q (target 66, BAC clone CTB-31J3) was not included
in the ﬁnal analysis because of repeatedly poor perfor-
mance, underscoring the importance of monitoring in-
dividual clone performance data (unpublished data). The
G-banding diagnosis was revealed to the experimenters
after ﬁnal array results were interpreted.
FISH Analysis
After decoding the blinded samples, any losses or gains
of a speciﬁc target clone(s) that did not correlate with the
previous karyotype were veriﬁed using FISH. The clone
on the array was used as the FISH probe in the analysis.
The DNA was directly labeled with Spectrum Orange
or Spectrum Green (Vysis/Abbott). The probes were hy-
bridized to slides prepared from the sample in question.
The probe and slide were codenatured on an automated
hybridization chamber (HyBrite, Vysis/Abbott) for 2min
at 73C. Slides were hybridized at 37C for 24 h and
were washed in 0.4# SSC/0.3% Tween 20 at 73C for
2 min, 2# SSC/0.1% NP-40 at 25C for 2 min, and 4#
SSC/0.1%Tween 20 at 25C for 4 min. Slides were coun-
terstained with DAPI in antifade solution and were an-
alyzed using a Zeiss Axiophot ﬂuorescence microscope
equipped with SmartCapture2 digital imaging software
(Digital Scientiﬁc). Analysis was performed on a mini-
mum of 50 interphase cells to verify array results.
Results
CGH-array analysis was utilized to examine 41 POC
samples in a blind study. The results from this analysis
were compared with results from G-banding analysis to
ascertain whether CGH arrays could verify all abnor-
malities found previously by G-banding analysis and to
discover whether additional, previously undetected sub-
microscopic rearrangements could be identiﬁed.
As shown in table 1, 37/41 POC cases analyzed by
array were in exact concordance with the karyotype re-
sults. Of these matches, 24 cases showed normal karyo-
type and CGH-array results. Thirteen matches showed
abnormal results for both tests, including 10 cases with
trisomies, 2 cases with sex chromosome abnormalities
(XYY and monosomy X), and 1 case with trisomy 17q
and monosomy 20q, consistent with an unbalanced
translocation.
As shown in table 1, the array identiﬁed additional
abnormalities that were not detected by routine chro-
mosome analysis in 4/41 (9.8%) cases. In case 15, the
array identiﬁed the trisomy 21 observed by G-banding
analysis but also suggested a trisomy for chromosome
20. The clones for chromosome 21 all showed ratios
11.2 with signiﬁcant P values, clearly indicating a gain.
For chromosome 20, the 20p telomere, 20q12, and 20q
telomere clones, which are spaced on each end and at
the middle of the chromosome, all showed increased
ratios with signiﬁcant P values, strongly suggesting a
gain. Furthermore, all clones between these three clones
showed slightly elevated T/R ratios. CGH-array analysis
uses the total genomic DNA of a sample and sets its
thresholds for gains (1.2) and losses (0.8) when 100%
of the genetic material is affected. However, it is theo-
retically possible that the elevated signals in this region
indicated that some, if not all, cells have additional ma-
terial from chromosome 20. The array analysis was re-
peated, and the same results were obtained. As shown
in ﬁgure 1A, subsequent FISH analysis veriﬁed the array
results by revealing two cell populations, one with tri-
somy 21 and one with trisomy 20 and trisomy 21. Thirty
percent of the cells exhibited trisomy 20 and trisomy 21,
with the remainder showing trisomy 21 only.
The trisomy 16 observed by G-banding analysis in
case 38 was conﬁrmed by CGH-array analysis. How-
ever, an interstitial duplication of 15q was also detected
by array analysis. The array analysis showed four clones
in the 15q11-q13 region (D15S11, SNRPN, UBE3A/
D15S10, and GABRB3) with ratios of 1.2. Figure 1B
shows a representative image from CGH-array analysis
of case 38. As shown in ﬁgure 1C, FISH analysis, with
a probe for SNRPN, veriﬁed this interstitial duplication.
In case 29, two arrays detected not only a trisomy
for chromosome 13 but also an interstitial deletion of
chromosome 9. Two clones at 9p21 showed a ratio of
0.81 but without a signiﬁcant P value. The clones on
either side of these two clones showed normal ratios.
We repeated this case on a second array and obtained
similar results for the two clones at 9p21. Therefore,
the data strongly suggest that case 29 exhibits a small
interstitial deletion in addition to trisomy 13. FISH vali-
dation was not possible for this case, since additional
cells were not available.
Finally, in case 40, two clones from the telomeric
region of the long arm of chromosome 10 showed ratios
of 1.25 and 1.39, suggestive of a duplication of this re-
gion. This result was veriﬁed by FISH analysis by use of
one of the 10q clones from the array.
Discussion
In this study, array-based CGH was compared with rou-
tine G banding for the detection of fetal chromosomal
abnormalities. Using array-based methods, we were able
to detect all abnormalities previously identiﬁed by G-
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Table 1
Comparison of Conventional Cytogenetic Analysis with Array-CGH Analysis
SAMPLE
RESULTS OF
MATCHaCytogenetic Analysis Array CGH
1 46,XX Normal Yes
2 46,XX Normal Yes
3 46,XX,der(20)t(17q;20q) Trisomy 17q, monosomy 20q Yes
4 46,XX Normal Yes
5 47,XY,21 Trisomy 21 Yes
6 47,XX,16 Trisomy 16 Yes
7 46,XY Normal Yes
8 47,XYY XYY Yes
9 46,XX Normal Yes
10 46,XX Normal Yes
11 46,XY Normal Yes
12 46,XX Normal Yes
13 46,XX Normal Yes
14 47,XY,14 Trisomy 14 Yes
15 47,XX,21 Trisomy 21, trisomy 20 Nob
16 46,XX Normal Yes
17 46,XX Normal Yes
18 46,XY Normal Yes
19 46,XX Normal Yes
20 46,XY Normal Yes
21 46,XY Normal Yes
22 46,XY Normal Yes
23 46,XX Normal Yes
24 45,X Monosomy X Yes
25 46,XY Normal Yes
26 47,XX,7 Trisomy 7 Yes
27 46,XX Normal Yes
28 47,XY,10 Trisomy 10 Yes
29 47,XY,13 Trisomy 13, del 9p21 Noc
30 46,XX Normal Yes
31 46,XX Normal Yes
32 46,XX Normal Yes
33 46,XX Normal Yes
34 47,XY,13 Trisomy 13 Yes
35 47,XX,7 Trisomy 7 Yes
36 47,XX,21 Trisomy 21 Yes
37 46,XX Normal Yes
38 47,XY,16 Trisomy 16, dup 15q Nod
39 47,XX,13 Trisomy 13 Yes
40 46,XX Dup 10qtel Noe
41 47,XX,16 Trisomy 16 Yes
a Match compares array results with conventional cytogenetic results; for those
that did not match, the additional abnormalities detected by array are described.
b FISH analysis with probes for the centromeres of chromosomes 20 and 21
veriﬁed mosaic trisomy for chromosome 20.
c Additional chromosome 9p21 deletion identiﬁed by array. Cells unavailable
for FISH veriﬁcation.
d Chromosome 15q duplication veriﬁed by FISH analysis.
e 10q telomere duplication veriﬁed by FISH analysis.
banding analysis. Additionally, four abnormalities were
detected by the array that were not identiﬁed by chro-
mosome analysis.
In case 15, the array data suggested mosaicism for
trisomy 20 that was not identiﬁed by cytogenetic analy-
sis. We pursued additional FISH analysis of the chro-
mosome 20 clones and veriﬁed themosaicism in this case,
becausemultiple clones on the array showed an abnormal
T/R ratio, demonstrating the usefulness of clone coverage
redundancy on arrays. Several factors could account for
the failure of cytogenetic analysis to detect the trisomy
20 cells. First, the cell line with trisomy 20 could be slow
to grow and divide, thereby presenting very few mitotic
cells of this type. It is interesting that this hypothesis is
Figure 1 Representative results from FISH and CGH-array analyses for cases 15 and 38. A, FISH veriﬁcation of trisomy 21 and mosaic
trisomy 20 array results for case 15. FISH probes corresponding to the centromeres of chromosome 20 (labeled with Spectrum Orange and
shown in red) and chromosome 21 (labeled with Spectrum Green and shown in green) were hybridized to interphase cells from case 15. The
cell on the left has trisomy for both chromosome 20 and chromosome 21, whereas the cell on the right shows only trisomy 21. There are only
two hybridization signals for chromosome 20, verifying mosaicism for this trisomy. B, Representative pseudocolored image from CGH-array
analysis for case 38, which has trisomy 16 and a duplication of the Prader-Willi/Angelman syndrome region on chromosome 15q. Male POC
DNA (green) was hybridized with female reference DNA (red). Each clone is spotted in triplicate on the array, and clones with a gain in the
POC sample are represented in green, loss in red, and normal copy number in gray. The green boxes mark the chromosome 16 clones that
showed trisomy. The white boxes highlight the clones from the Prader-Willi/Angelman syndrome region that are duplicated; the corresponding
ratios are shown next to each target. The other red and green signals correspond to clones from the X or Y chromosomes, respectively. C,
Interphase FISH analysis of case 38 verifying the interstitial duplication of chromosome 15 that was identiﬁed by CGH array. A probe for the
SNRPN gene (red) was used to test for the 15q11-q13 duplication, and a probe for the PML gene (green) in distal 15q was used as a control.
In each cell, the small arrow points to the normal signal for SNRPN, and the large arrow indicates the duplicated chromosome 15, which
shows two hybridization signals for SNRPN.
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supported by the observation that trisomy for chromo-
some 20 was observed only in interphase cells and not
in metaphase cells. It is also possible that a trisomy 20
cell could have been detected by cytogenetic analysis, but,
since the diagnosis of trisomy 21was already established,
it was not further investigated. This example highlights
two limitations of cytogenetic analysis, principally its re-
liance on cell culture and on subjective analysis of met-
aphase spreads, while illustrating the objective nature of
DNA-basedCGH-array analysis. It also demonstrates the
potential for CGH-array results to suggest the presence
of mosaicism.
A duplication of the proximal region of chromosome
15 was found in case 38, in addition to a previously
identiﬁed trisomy. Although trisomy for chromosome
16 is the likely cause of the spontaneous abortion, the
chromosome 15 duplication, if maternally inherited, has
been associated with autistic disorder (Cook et al. 1997).
Therefore, this ﬁnding could have important implica-
tions for genetic counseling and subsequent pregnan-
cies. In addition to identifying the most likely cause of
the miscarriage, case 38 shows the ability of array CGH
to yield new, more complete diagnoses that may provide
additional important information.
Through the detection of all chromosomal anomalies
that were reported by routine G-banding analysis and
the identiﬁcation of four new abnormalities not detected
by cytogenetic analysis, the efﬁcacy of array-basedCGH
in analyzing POC samples has been established. In ad-
dition, this study demonstrates how several key short-
comings associated with routine cytogenetic methods of
analysis of POCs could be avoided by use of this method.
In array CGH, the use of genomic DNA circumvents the
culture of fetal cells and the many problems (culture con-
tamination, maternal overgrowth of cells, poor chromo-
some morphology, or culture failure) inherent in that
technique. Moreover, the potential higher resolution of
genomic microarrays allows for the detection of smaller
unbalanced duplications and deletions of the genome.
These factors, together with the objective nature of array
CGH analysis, allows for a more reﬁned and complete
diagnosis.
The detection capabilities of array CGH are limited
by the format of the array being used. In this study, the
GenoSensor Array 300 was utilized over a higher-den-
sity array, such as an array with a 1-Mb resolution.
Although a higher resolution could be obtained with a
different array, the lower-density array was used, since
it contains clinically relevant clones currently implicated
in cytogenetic diagnoses, which is important for inter-
preting the signiﬁcance of the results. In addition, both
conventional and array-based CGH are limited, in being
unable to detect polyploidies and balanced chromoso-
mal rearrangements. Lomax et al. (2000) used ﬂow cy-
tometry as an adjunct to CGH to test for triploidy or
tetraploidy. Alternatively, interphase FISH analysis of
cells prepared from uncultured fetal tissue could be used
to test the ploidy level or to validate results from array
analysis.
Additional large-scale, prospective studies with un-
cultured POC samples—as well as peripheral blood, am-
niotic ﬂuid, and other specimen types—need to be con-
ducted to further assess the feasibility of utilizing array
CGH in the clinical cytogenetics-laboratory setting.
CGH-array analysis has the potential advantage of be-
ing automatable and of providing a shorter time frame
for obtaining results. Future studies can test the beneﬁts
of the array technique in regard to higher detection pa-
rameters, more accurate and less failure-prone diag-
noses, and a greater ease of use, as compared with con-
ventional cytogenetic analysis.
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